SCHEMBL15538434

SCHEMBL15538434

COC(=O)c1ccc(-c2ccc(NCC3CCN(CC(C)(C)F)CC3)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 1/20 0.47
SSTR5 P35346 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 1/20 0.42
RAB9A P51151 1/20 0.42
ACHE P22303 1/20 0.42
BACE1 P56817 1/20 0.42
POLB P06746 1/20 0.41
LTA4H P09960 1/20 0.41
LMNA P02545 2/20 0.40
MAPT P10636 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CHKA P35790 1/20 0.39
THRB P10828 1/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16777015 0.92 CHRM4 (0.46) CHRM4SSTR5MEN1KMT2AALDH1A1
SCHEMBL15538494 0.89 SSTR5 (0.53) CHRM4SSTR5ACHEBACE1LTA4H
SCHEMBL21534964 0.84 HRH3 (0.43) SSTR5MEN1KMT2AALDH1A1RAB9A
SCHEMBL15538973 0.83 DRD2 (0.48) CHRM4SSTR5MAPTKDM4E
SCHEMBL15540325 0.82 HDAC4 (0.46) SSTR5LMNA
SCHEMBL15551177 0.82 HDAC4 (0.46) SSTR5LMNA
SCHEMBL16777422 0.82 CHRM4 (0.43) CHRM4SSTR5MEN1KMT2AALDH1A1
SCHEMBL15540337 0.80 SSTR5 (0.52) CHRM4SSTR5ACHEBACE1LTA4H
SCHEMBL15537903 0.80 GRM3 (0.42) SSTR5KMT2AALDH1A1POLBMAPT
SCHEMBL16777498 0.80 POLB (0.46) SSTR5POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 CHRM4 669/4885SSTR5 104/4885MEN1 4166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.